ScholarIQanswers from OpenAlex

Prevalence and trend of biopsy-proven IgA nephropathy in China: a systematic review

PaperCitations, authors & open-access status

Prevalence and trend of biopsy-proven IgA nephropathy in China: a systematic review is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Prevalence and trend of biopsy-proven IgA nephropathy in China: a systematic review have?

ScholarIQcitation count

Prevalence and trend of biopsy-proven IgA nephropathy in China: a systematic review has 8 citations in the OpenAlex counts ScholarIQ stores.

When was Prevalence and trend of biopsy-proven IgA nephropathy in China: a systematic review published?

ScholarIQyear

Prevalence and trend of biopsy-proven IgA nephropathy in China: a systematic review has 2025 year in the ScholarIQ index.

What is the open-access status of Prevalence and trend of biopsy-proven IgA nephropathy in China: a systematic review?

ScholarIQoa status

Prevalence and trend of biopsy-proven IgA nephropathy in China: a systematic review has closed oa status in the ScholarIQ index.

What is the DOI of Prevalence and trend of biopsy-proven IgA nephropathy in China: a systematic review?

ScholarIQdoi

The DOI for Prevalence and trend of biopsy-proven IgA nephropathy in China: a systematic review is on the source record.

What is the PMID of Prevalence and trend of biopsy-proven IgA nephropathy in China: a systematic review?

ScholarIQpmid

The PMID for Prevalence and trend of biopsy-proven IgA nephropathy in China: a systematic review is on the source record.

What is the OpenAlex record for Prevalence and trend of biopsy-proven IgA nephropathy in China: a systematic review?

ScholarIQopenalex

The OpenAlex for Prevalence and trend of biopsy-proven IgA nephropathy in China: a systematic review is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial